EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Adverse Effects Under Th2 Biologics (Dupilumab and Tezepelumab) in a Patient with Severe Asthma and Atopic Dermatitis

Hendrik Suhling, Christopher Alexander Hinze, Tobias Welte, Thomas Werfel, Stephan Traidl

Respiration · 2023

DOI: 10.1159/000534924 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Respiration, 2023. Verfasst von Hendrik Suhling und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine and Infectious Diseases/Hannover Medical School, Hannover, Germany. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Biological Products, Asthma. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction: This is the first report of a patient with severe asthma and atopic dermatitis that developed local perioral skin infection which onset coincided with the patient’s treatment with dupilumab (candida albicans) and later with tezepelumab (microscopic detection of yeast). Case Presentation: Besides moderate headache, macular exanthema was found after administration of tezepelumab, which was subsequently accompanied by a worsening of symptoms upon reexposure to the treatment. Both sensations needed multidisciplinary treatment and both antibody therapies were stopped.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatitis, AtopicBiological ProductsAsthmaHumansAntibodies, MonoclonalTreatment OutcomeAntibodies, Monoclonal, Humanized

Stichwörter der Autor:innen

DupilumabSevere asthmaSide effectsTezepelumab

Substanzen

Antibodies, MonoclonalBiological ProductstezepelumabAntibodies, Monoclonal, Humanizeddupilumab

Autor:innen und Institutionen

  • Department of Respiratory Medicine and Infectious Diseases/Hannover Medical School, Hannover, Germany.
  • Department of Dermatology and Allergy, Hannover Medical School, Hannover, Germany.

Zitieren

APA

Suhling, H., Hinze, C. A., Welte, T., Werfel, T., & Traidl, S. (2023). Adverse Effects Under Th2 Biologics (Dupilumab and Tezepelumab) in a Patient with Severe Asthma and Atopic Dermatitis. Respiration. https://doi.org/10.1159/000534924

Vancouver

Suhling H, Hinze CA, Welte T, Werfel T, Traidl S. Adverse Effects Under Th2 Biologics (Dupilumab and Tezepelumab) in a Patient with Severe Asthma and Atopic Dermatitis. Respiration. 2023. doi:10.1159/000534924

BibTeX
@article{Suhling2023,
  author = {Suhling, Hendrik and Hinze, Christopher Alexander and Welte, Tobias and Werfel, Thomas and Traidl, Stephan},
  title = {Adverse Effects Under Th2 Biologics (Dupilumab and Tezepelumab) in a Patient with Severe Asthma and Atopic Dermatitis},
  journal = {Respiration},
  year = {2023},
  doi = {10.1159/000534924}
}
Kostenlos starten →